TAR-200 MONOTHERAPY IN PATIENTS WITH BACILLUS CALMETTE-GUÉRIN–UNRESPONSIVE PAPILLARY DISEASE–ONLY HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER: FIRST RESULTS FROM COHORT 4 OF SUNRISE-1 | Publicación